Cargando…
In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
AIMS: Hepatitis B Virus (HBV) infection is the major risk factor for hepatocellular carcinoma (HCC) in East Asia. Here we aimed to further investigate the abundance of viral antigen and DNA within HBV-related HCC and surrounding tissues at histological level. METHOD: In addition to routine histopath...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761330/ https://www.ncbi.nlm.nih.gov/pubmed/35034659 http://dx.doi.org/10.1186/s13000-022-01194-8 |
_version_ | 1784633505056030720 |
---|---|
author | Zheng, Ye Xu, Mingzhu Zeng, Dong Tong, Haitao Shi, Yuhan Feng, Yanling Zhang, Xiaonan |
author_facet | Zheng, Ye Xu, Mingzhu Zeng, Dong Tong, Haitao Shi, Yuhan Feng, Yanling Zhang, Xiaonan |
author_sort | Zheng, Ye |
collection | PubMed |
description | AIMS: Hepatitis B Virus (HBV) infection is the major risk factor for hepatocellular carcinoma (HCC) in East Asia. Here we aimed to further investigate the abundance of viral antigen and DNA within HBV-related HCC and surrounding tissues at histological level. METHOD: In addition to routine histopathology, in situ hybridization (ISH) of HBV DNA and immunohistochemistry (IHC) of HBsAg were performed in tissues from 131 HBsAg-positive HCC patients undergoing liver resection. Serum α-fetoprotein together with basic biochemical and immunological parameter was also measured. RESULTS: Overall, the ISH of HBV DNA and IHC of HBsAg showed 31.3% and 92.9% positive rate respectively (p < 0.0001). The level of correlation between these two markers was much more significant in tumor (p < 0.0001) than in tumor-surrounding tissue (p = 0.01). HBsAg exhibited a much higher positive rate in tumor-adjacent tissue than in tumor tissue (86.6% versus 29.9%, p < 0.0001) with significantly different staining pattern. By contrast, the positive rate of HBV DNA ISH was comparable in tumor and surrounding tissue (17.6% versus 22.9%, p = 0.36). Yet the HBV DNA signal in tumor tissue showed predominant nuclear localization (87.0%) whereas staining pattern in adjacent tissue was mixed (43.3% nuclear localization, p = 0.0015). Finally, no significant association between intra-tumor HBV DNA/HBsAg positivity and major histological markers (microvascular invasion, tumor differentiation, etc.) or recurrence after surgery was observed. CONCLUSIONS: These data confirmed the largely integrated state of HBV DNA, weaker expression and altered localization of surface antigen in tumor compared with surrounding tissue. The strikingly different prevalence and localization of HBsAg and HBV DNA reflected the complex and heterogeneous mechanisms leading to HBV-induced tumorigenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-022-01194-8. |
format | Online Article Text |
id | pubmed-8761330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87613302022-01-18 In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma Zheng, Ye Xu, Mingzhu Zeng, Dong Tong, Haitao Shi, Yuhan Feng, Yanling Zhang, Xiaonan Diagn Pathol Research AIMS: Hepatitis B Virus (HBV) infection is the major risk factor for hepatocellular carcinoma (HCC) in East Asia. Here we aimed to further investigate the abundance of viral antigen and DNA within HBV-related HCC and surrounding tissues at histological level. METHOD: In addition to routine histopathology, in situ hybridization (ISH) of HBV DNA and immunohistochemistry (IHC) of HBsAg were performed in tissues from 131 HBsAg-positive HCC patients undergoing liver resection. Serum α-fetoprotein together with basic biochemical and immunological parameter was also measured. RESULTS: Overall, the ISH of HBV DNA and IHC of HBsAg showed 31.3% and 92.9% positive rate respectively (p < 0.0001). The level of correlation between these two markers was much more significant in tumor (p < 0.0001) than in tumor-surrounding tissue (p = 0.01). HBsAg exhibited a much higher positive rate in tumor-adjacent tissue than in tumor tissue (86.6% versus 29.9%, p < 0.0001) with significantly different staining pattern. By contrast, the positive rate of HBV DNA ISH was comparable in tumor and surrounding tissue (17.6% versus 22.9%, p = 0.36). Yet the HBV DNA signal in tumor tissue showed predominant nuclear localization (87.0%) whereas staining pattern in adjacent tissue was mixed (43.3% nuclear localization, p = 0.0015). Finally, no significant association between intra-tumor HBV DNA/HBsAg positivity and major histological markers (microvascular invasion, tumor differentiation, etc.) or recurrence after surgery was observed. CONCLUSIONS: These data confirmed the largely integrated state of HBV DNA, weaker expression and altered localization of surface antigen in tumor compared with surrounding tissue. The strikingly different prevalence and localization of HBsAg and HBV DNA reflected the complex and heterogeneous mechanisms leading to HBV-induced tumorigenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-022-01194-8. BioMed Central 2022-01-16 /pmc/articles/PMC8761330/ /pubmed/35034659 http://dx.doi.org/10.1186/s13000-022-01194-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zheng, Ye Xu, Mingzhu Zeng, Dong Tong, Haitao Shi, Yuhan Feng, Yanling Zhang, Xiaonan In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma |
title | In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma |
title_full | In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma |
title_fullStr | In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma |
title_full_unstemmed | In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma |
title_short | In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma |
title_sort | in situ analysis of hepatitis b virus (hbv) antigen and dna in hbv-induced hepatocellular carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761330/ https://www.ncbi.nlm.nih.gov/pubmed/35034659 http://dx.doi.org/10.1186/s13000-022-01194-8 |
work_keys_str_mv | AT zhengye insituanalysisofhepatitisbvirushbvantigenanddnainhbvinducedhepatocellularcarcinoma AT xumingzhu insituanalysisofhepatitisbvirushbvantigenanddnainhbvinducedhepatocellularcarcinoma AT zengdong insituanalysisofhepatitisbvirushbvantigenanddnainhbvinducedhepatocellularcarcinoma AT tonghaitao insituanalysisofhepatitisbvirushbvantigenanddnainhbvinducedhepatocellularcarcinoma AT shiyuhan insituanalysisofhepatitisbvirushbvantigenanddnainhbvinducedhepatocellularcarcinoma AT fengyanling insituanalysisofhepatitisbvirushbvantigenanddnainhbvinducedhepatocellularcarcinoma AT zhangxiaonan insituanalysisofhepatitisbvirushbvantigenanddnainhbvinducedhepatocellularcarcinoma |